CD8A and neoplasm: Studies have shown that lung metastatic OS organoids preserve the original morphology of the tumor and tissue features, as well as respond to immune checkpoint inhibitors by reactivating CD8+ T cell cytotoxic function, increasing the proportion of CD8+/CD4+ T cells in the total CD3+ T cell population (He et al., 2020).